| Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity MD Kornberg, P Bhargava, PM Kim, V Putluri, AM Snowman, N Putluri, ... Science 360 (6387), 449-453, 2018 | 626 | 2018 |
| Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four‐year study S Saidha, O Al‐Louzi, JN Ratchford, P Bhargava, J Oh, SD Newsome, ... Annals of neurology 78 (5), 801-813, 2015 | 432 | 2015 |
| Animal models of sleep disorders LA Toth, P Bhargava Comparative medicine 63 (2), 91-104, 2013 | 205 | 2013 |
| Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis ES Sotirchos, P Bhargava, C Eckstein, K Van Haren, M Baynes, A Ntranos, ... Neurology 86 (4), 382-390, 2016 | 185 | 2016 |
| Gut microbiome and multiple sclerosis P Bhargava, EM Mowry Current neurology and neuroscience reports 14, 1-8, 2014 | 172 | 2014 |
| Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation P Bhargava, MD Smith, L Mische, E Harrington, KC Fitzgerald, K Martin, ... The Journal of clinical investigation 130 (7), 3467-3482, 2020 | 170 | 2020 |
| Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics OG Vidaurre, JD Haines, I Katz Sand, KP Adula, JL Huynh, CA McGraw, ... Brain 137 (8), 2271-2286, 2014 | 154 | 2014 |
| Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation P Bhargava, KC Fitzgerald, PA Calabresi, EM Mowry JCI insight 2 (19), e95302, 2017 | 114 | 2017 |
| Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy SP Gadani, M Reyes-Mantilla, L Jank, S Harris, M Douglas, MD Smith, ... EBioMedicine 73, 2021 | 109 | 2021 |
| Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: a retrospective study J Button, O Al-Louzi, A Lang, P Bhargava, SD Newsome, T Frohman, ... Neurology 88 (6), 525-532, 2017 | 95 | 2017 |
| Improved visualization of cortical lesions in multiple sclerosis using 7T MP2RAGE ES Beck, P Sati, V Sethi, T Kober, B Dewey, P Bhargava, G Nair, ... American Journal of Neuroradiology 39 (3), 459-466, 2018 | 91 | 2018 |
| The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis P Bhargava, S Cassard, SU Steele, C Azevedo, D Pelletier, EA Sugar, ... Contemporary clinical trials 39 (2), 288-293, 2014 | 91 | 2014 |
| Outer retinal changes following acute optic neuritis OA Al-Louzi, P Bhargava, SD Newsome, LJ Balcer, EM Frohman, ... Multiple Sclerosis Journal 22 (3), 362-372, 2016 | 87 | 2016 |
| Automatic segmentation of microcystic macular edema in OCT A Lang, A Carass, EK Swingle, O Al-Louzi, P Bhargava, S Saidha, ... Biomedical optics express 6 (1), 155-169, 2014 | 82 | 2014 |
| Lipidomic characterization of extracellular vesicles in human serum S Chen, A Datta-Chaudhuri, P Deme, A Dickens, R Dastgheyb, ... Journal of circulating biomarkers 8 (1), 2019 | 81 | 2019 |
| Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course B Nourbakhsh, P Bhargava, H Tremlett, J Hart, J Graves, E Waubant Annals of clinical and translational neurology 5 (10), 1211-1221, 2018 | 75 | 2018 |
| Your Patients with Multiple Sclerosis have Set Wellness as a High Priority— And the National Multiple Sclerosis Society is Responding M Dunn, P Bhargava, R Kalb US Neurology 11 (2), 80-6, 2015 | 74 | 2015 |
| Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls P Bhargava, SU Steele, E Waubant, NR Revirajan, J Marcus, M Dembele, ... Multiple Sclerosis Journal 22 (6), 753-760, 2016 | 70 | 2016 |
| Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism KC Fitzgerald, MD Smith, S Kim, ES Sotirchos, MD Kornberg, M Douglas, ... Cell Reports Medicine 2 (10), 2021 | 69 | 2021 |
| Dimethyl fumarate alters B‐cell memory and cytokine production in MS patients MD Smith, KA Martin, PA Calabresi, P Bhargava Annals of clinical and translational neurology 4 (5), 351-355, 2017 | 69 | 2017 |
Peter Calabresijohns hopkinsVerified email at jhmi.edu
